NCT00004317View on ClinicalTrials.gov

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Toxoplasmosis
Interventions
DRUG

Leucovorin calcium

See arm descriptions

DRUG

Pyrimethamine

See arm descriptions

DRUG

Spiramycin

Spiramycin is administered before the fetal diagnosis is made.

DRUG

Sulfadiazine

See arm descriptions

Trial Locations (1)

60637

RECRUITING

University of Chicago, Chicago

All Listed Sponsors
collaborator

University of Chicago

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH